DOCELIEVA 120MG ( Docetaxel Injection IP 120 MG )

Docelieva 120 mg contains Docetaxel, a chemotherapy (anticancer) medicine belonging to the taxane group. It works by stabilizing microtubules and preventing their depolymerization, thereby inhibiting mitosis and causing death of rapidly dividing cancer cells.

Docetaxel Injection is used in the treatment of:

1. Breast cancer

2. Non-small cell lung cancer (NSCLC)

3. Prostate cancer (metastatic, hormone-refractory)

4. Gastric (stomach) cancer

5. Head and neck squamous cell carcinoma

Common side effects:

• Hair loss (alopecia)

• Nausea, vomiting

• Myelosuppression (especially neutropenia)

• Fatigue and weakness

• Peripheral neuropathy

• Fluid retention (edema, weight gain)

• Mouth sores (stomatitis)

Serious side effects:

• Severe neutropenia with infections

• Hypersensitivity reactions

• Severe fluid retention (pleural effusion, ascites)

• Liver function abnormalities

Premedication with corticosteroids (e.g., dexamethasone) is mandatory to reduce hypersensitivity reactions and fluid retention.

Dosage is individualized based on body surface area (BSA), cancer type, and chemotherapy regimen.

Common dosing schedules:

• 75 mg/m² IV infusion every 3 weeks

• 100 mg/m² IV infusion every 3 weeks (in selected cases)

 Administered as a slow intravenous infusion under strict oncologist supervision.

NOTE: This medicine should be taken only under a doctor’s supervision.